Dr. Paul Fernyhough

Biography

Paul Fernyhough is a renowned researcher in the field of neurodegeneration and neuronal regeneration. Born and educated in East London, UK, he received a Bachelor of Science degree in biological sciences at the University of Essex and completed his PhD in biochemistry at the University of Sheffield. Following his PhD, he undertook postdoctoral research at esteemed institutions including Colorado State University, King's College London, and as a Wellcome Trust Postdoctoral Fellow at St. Bartholomew’s Medical College. In 1998, Fernyhough joined the School of Biological Sciences at the University of Manchester as a tenured lecturer. He then moved to Canada to join the Max Rady College of Medicine at the University of Manitoba as a professor of pharmacology and therapeutics. His research focuses on understanding the mechanisms of nerve damage, particularly in diabetes and neurodegenerative diseases like Alzheimer's disease, exploring cholinergic signaling, GPCR signaling, bioenergetics, and drug design. He is also the director of the division of neurodegenerative disorders at St. Boniface Hospital Albrechtsen Research Centre and co-founder of WinSanTor Inc., a biotech company supporting clinical trials for peripheral neuropathy. Fernyhough's work aims to significantly improve the lives of millions suffering from diabetes and other neurodegenerative disorders.

Research Interests

Experience